| ROI Name | ∑ In | % In | log ratio | ∑ Out | % Out |
|---|---|---|---|---|---|
| PLP(L) | 129 | 63.5% | -0.43 | 96 | 57.5% |
| CentralBrain-unspecified | 32 | 15.8% | -0.48 | 23 | 13.8% |
| SCL(L) | 27 | 13.3% | -0.85 | 15 | 9.0% |
| SLP(L) | 9 | 4.4% | 1.29 | 22 | 13.2% |
| CA(L) | 1 | 0.5% | 2.58 | 6 | 3.6% |
| LH(L) | 0 | 0.0% | inf | 4 | 2.4% |
| Optic-unspecified(L) | 3 | 1.5% | -inf | 0 | 0.0% |
| WED(L) | 2 | 1.0% | -1.00 | 1 | 0.6% |
| upstream partner | # | NT | conns PLP171 | % In | CV |
|---|---|---|---|---|---|
| LHAV3p1 (L) | 1 | Glu | 30 | 15.5% | 0.0 |
| CL234 (L) | 2 | Glu | 28 | 14.5% | 0.4 |
| WED093 (R) | 2 | ACh | 16 | 8.3% | 0.4 |
| WED092 (L) | 3 | ACh | 16 | 8.3% | 0.5 |
| WED093 (L) | 2 | ACh | 15 | 7.8% | 0.1 |
| VP1m+VP2_lvPN2 (L) | 3 | ACh | 9 | 4.7% | 0.3 |
| WED092 (R) | 3 | ACh | 7 | 3.6% | 0.8 |
| WEDPN10B (R) | 1 | GABA | 5 | 2.6% | 0.0 |
| CB3013 (L) | 1 | unc | 4 | 2.1% | 0.0 |
| WED089 (L) | 1 | ACh | 4 | 2.1% | 0.0 |
| PLP039 (L) | 2 | Glu | 4 | 2.1% | 0.5 |
| WED089 (R) | 1 | ACh | 3 | 1.6% | 0.0 |
| PLP023 (L) | 1 | GABA | 3 | 1.6% | 0.0 |
| LoVP36 (L) | 1 | Glu | 3 | 1.6% | 0.0 |
| VP1l+VP3_ilPN (L) | 1 | ACh | 3 | 1.6% | 0.0 |
| LHPV2a1_a (L) | 2 | GABA | 3 | 1.6% | 0.3 |
| CB3759 (L) | 1 | Glu | 2 | 1.0% | 0.0 |
| LHPD2a6 (L) | 1 | Glu | 2 | 1.0% | 0.0 |
| CB1368 (L) | 1 | Glu | 2 | 1.0% | 0.0 |
| PVLP109 (L) | 1 | ACh | 2 | 1.0% | 0.0 |
| WED091 (L) | 1 | ACh | 2 | 1.0% | 0.0 |
| WEDPN10A (R) | 1 | GABA | 2 | 1.0% | 0.0 |
| LoVP67 (L) | 1 | ACh | 2 | 1.0% | 0.0 |
| M_smPN6t2 (R) | 1 | GABA | 2 | 1.0% | 0.0 |
| LC20a (L) | 1 | ACh | 1 | 0.5% | 0.0 |
| CB0656 (L) | 1 | ACh | 1 | 0.5% | 0.0 |
| LHPV6k2 (L) | 1 | Glu | 1 | 0.5% | 0.0 |
| LoVP35 (L) | 1 | ACh | 1 | 0.5% | 0.0 |
| PLP217 (L) | 1 | ACh | 1 | 0.5% | 0.0 |
| CB2262 (L) | 1 | Glu | 1 | 0.5% | 0.0 |
| PLP042_c (L) | 1 | unc | 1 | 0.5% | 0.0 |
| PLP042_b (L) | 1 | Glu | 1 | 0.5% | 0.0 |
| PLP159 (L) | 1 | GABA | 1 | 0.5% | 0.0 |
| VP2+_adPN (L) | 1 | ACh | 1 | 0.5% | 0.0 |
| WEDPN17_a1 (L) | 1 | ACh | 1 | 0.5% | 0.0 |
| PLP160 (L) | 1 | GABA | 1 | 0.5% | 0.0 |
| ATL012 (L) | 1 | ACh | 1 | 0.5% | 0.0 |
| PLP042_a (L) | 1 | Glu | 1 | 0.5% | 0.0 |
| CB3140 (R) | 1 | ACh | 1 | 0.5% | 0.0 |
| SMP145 (L) | 1 | unc | 1 | 0.5% | 0.0 |
| PLP119 (L) | 1 | Glu | 1 | 0.5% | 0.0 |
| LoVP16 (L) | 1 | ACh | 1 | 0.5% | 0.0 |
| M_lPNm11C (L) | 1 | ACh | 1 | 0.5% | 0.0 |
| VP1m+VP2_lvPN1 (L) | 1 | ACh | 1 | 0.5% | 0.0 |
| LHPV6m1 (L) | 1 | Glu | 1 | 0.5% | 0.0 |
| aMe3 (L) | 1 | Glu | 1 | 0.5% | 0.0 |
| AN27X017 (L) | 1 | ACh | 1 | 0.5% | 0.0 |
| OA-VUMa3 (M) | 1 | OA | 1 | 0.5% | 0.0 |
| downstream partner | # | NT | conns PLP171 | % Out | CV |
|---|---|---|---|---|---|
| LHPV6m1 (L) | 1 | Glu | 24 | 9.2% | 0.0 |
| WEDPN12 (L) | 1 | Glu | 20 | 7.7% | 0.0 |
| LHPV4c1_c (L) | 3 | Glu | 18 | 6.9% | 0.5 |
| SLP221 (L) | 1 | ACh | 15 | 5.8% | 0.0 |
| LHPV6p1 (L) | 1 | Glu | 12 | 4.6% | 0.0 |
| CB3071 (L) | 1 | Glu | 8 | 3.1% | 0.0 |
| SLP304 (L) | 1 | unc | 8 | 3.1% | 0.0 |
| LHPD2a6 (L) | 2 | Glu | 8 | 3.1% | 0.0 |
| VP2+_adPN (L) | 1 | ACh | 7 | 2.7% | 0.0 |
| CB4119 (L) | 2 | Glu | 7 | 2.7% | 0.7 |
| ATL020 (L) | 2 | ACh | 7 | 2.7% | 0.1 |
| CL234 (L) | 2 | Glu | 7 | 2.7% | 0.1 |
| LHPV5m1 (L) | 2 | ACh | 6 | 2.3% | 0.7 |
| CB3141 (L) | 2 | Glu | 6 | 2.3% | 0.3 |
| LHPV6k1 (L) | 3 | Glu | 6 | 2.3% | 0.4 |
| PLP130 (L) | 1 | ACh | 5 | 1.9% | 0.0 |
| CB2904 (L) | 1 | Glu | 5 | 1.9% | 0.0 |
| CB1901 (L) | 2 | ACh | 5 | 1.9% | 0.6 |
| SLP080 (L) | 1 | ACh | 4 | 1.5% | 0.0 |
| CB1326 (L) | 1 | ACh | 3 | 1.2% | 0.0 |
| PLP048 (L) | 1 | Glu | 3 | 1.2% | 0.0 |
| SLP337 (L) | 1 | Glu | 3 | 1.2% | 0.0 |
| CB2713 (L) | 1 | ACh | 3 | 1.2% | 0.0 |
| LHPV6q1 (L) | 1 | unc | 3 | 1.2% | 0.0 |
| SMP252 (L) | 1 | ACh | 2 | 0.8% | 0.0 |
| SMP461 (L) | 1 | ACh | 2 | 0.8% | 0.0 |
| CB4112 (L) | 1 | Glu | 2 | 0.8% | 0.0 |
| LHPV4c4 (L) | 1 | Glu | 2 | 0.8% | 0.0 |
| SMP257 (L) | 1 | ACh | 2 | 0.8% | 0.0 |
| LHPV4b3 (L) | 1 | Glu | 2 | 0.8% | 0.0 |
| WEDPN6B (L) | 1 | GABA | 2 | 0.8% | 0.0 |
| CB2733 (L) | 1 | Glu | 2 | 0.8% | 0.0 |
| CL141 (L) | 1 | Glu | 2 | 0.8% | 0.0 |
| SLP460 (L) | 1 | Glu | 2 | 0.8% | 0.0 |
| PLP247 (L) | 1 | Glu | 2 | 0.8% | 0.0 |
| SMP237 (L) | 1 | ACh | 2 | 0.8% | 0.0 |
| PPL202 (L) | 1 | DA | 2 | 0.8% | 0.0 |
| LoVCLo2 (L) | 1 | unc | 2 | 0.8% | 0.0 |
| CB1699 (L) | 2 | Glu | 2 | 0.8% | 0.0 |
| PLP160 (L) | 2 | GABA | 2 | 0.8% | 0.0 |
| FB2A (L) | 2 | DA | 2 | 0.8% | 0.0 |
| CL008 (L) | 2 | Glu | 2 | 0.8% | 0.0 |
| SIP013 (L) | 1 | Glu | 1 | 0.4% | 0.0 |
| CB1976 (L) | 1 | Glu | 1 | 0.4% | 0.0 |
| CB0656 (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| SLP134 (L) | 1 | Glu | 1 | 0.4% | 0.0 |
| CB2262 (L) | 1 | Glu | 1 | 0.4% | 0.0 |
| AVLP486 (L) | 1 | GABA | 1 | 0.4% | 0.0 |
| LHPD2c6 (L) | 1 | Glu | 1 | 0.4% | 0.0 |
| CB3240 (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| CB3076 (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| LHPV6f1 (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| CB0943 (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| CB1899 (L) | 1 | Glu | 1 | 0.4% | 0.0 |
| CB2881 (L) | 1 | Glu | 1 | 0.4% | 0.0 |
| CB3013 (L) | 1 | unc | 1 | 0.4% | 0.0 |
| LAL188_b (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| WEDPN7B (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| PLP042_c (L) | 1 | unc | 1 | 0.4% | 0.0 |
| CB1467 (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| SMP091 (L) | 1 | GABA | 1 | 0.4% | 0.0 |
| LAL188_a (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| LHPV2c2 (L) | 1 | unc | 1 | 0.4% | 0.0 |
| KCg-s3 (L) | 1 | DA | 1 | 0.4% | 0.0 |
| SMP380 (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| PLP026 (L) | 1 | GABA | 1 | 0.4% | 0.0 |
| LHPV2b4 (L) | 1 | GABA | 1 | 0.4% | 0.0 |
| LHPV2a3 (L) | 1 | GABA | 1 | 0.4% | 0.0 |
| LHPV2a1_c (L) | 1 | GABA | 1 | 0.4% | 0.0 |
| SMP183 (L) | 1 | ACh | 1 | 0.4% | 0.0 |
| LHPV6m1 (R) | 1 | Glu | 1 | 0.4% | 0.0 |
| WEDPN12 (R) | 1 | Glu | 1 | 0.4% | 0.0 |
| LHAV3p1 (L) | 1 | Glu | 1 | 0.4% | 0.0 |
